文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

腹腔镜袖状胃切除术在Child-Pugh A级门静脉高压患者中的安全性与有效性

Safety and efficacy of laparoscopic sleeve gastrectomy in patients with portal hypertension with liver function of Childs A.
PubMed 文献 · Surg Endosc · 2021-06-15

该回顾性研究评估了15例Child-Pugh A级门静脉高压(经内镜证实存在食管静脉曲张)肥胖患者行腹腔镜袖状胃切除术(SG)的可行性。结果显示平均手术时间77.33±15.22分钟,平均出血量80.67±37.12毫升,平均住院2.73±0.59天,无术中或术后早期并发症,无输血。术后1年体重、BMI、超重体重减少百分比(EBWL%)、总体重减少(TWL)及TWL%分别为86.05±14.40 kg、31.16 kg/m2±3.82、63.84%±15.24、31.49±9.54 kg和26.50±5.42%。1年糖尿病和高血压缓解率分别为80%和72.72%。平均随访3±1.5年,无近期或远期并发症和死亡。结论认为SG对经仔细选择的门静脉高压患者是可行且安全的选择。

要点

  • Child-Pugh A级门静脉高压患者行腹腔镜袖状胃切除术未出现术中或术后早期并发症。
  • 术后1年EBWL%为63.84%±15.24,糖尿病和高血压缓解率分别为80%和72.72%。
  • 平均随访3±1.5年无近期或远期并发症和死亡。

核心结论

  • 腹腔镜袖状胃切除术对经仔细选择的Child-Pugh A级门静脉高压肥胖患者是可行且安全的选择,可获得良好的体重减轻和合并症缓解。

研究设计与样本

  • 回顾性研究,纳入15例经内镜证实存在食管静脉曲张的门静脉高压患者,所有患者肝功能均为Child-Pugh A级,均行腹腔镜袖状胃切除术。

主要发现

  • 平均手术时间77.33±15.22分钟,平均出血量80.67±37.12毫升,平均住院时间2.73±0.59天。
  • 无术中或术后早期并发症,术后无需输血。
  • 术后1年体重86.05±14.40 kg,BMI 31.16 kg/m2±3.82,EBWL% 63.84%±15.24,TWL 31.49±9.54 kg,TWL% 26.50±5.42%。
  • 术后1年糖尿病缓解率80%,高血压缓解率72.72%。
  • 平均随访3±1.5年,无近期或远期并发症和死亡。

临床怎么用

  • 对于Child-Pugh A级且内镜证实存在食管静脉曲张的门静脉高压肥胖患者,在仔细选择的前提下可考虑行腹腔镜袖状胃切除术。

局限性

  • 本研究为回顾性研究,样本量仅15例,所有患者均为Child-Pugh A级,结论不能外推至肝功能较差的门静脉高压患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Advanced liver disease and portal hypertension (PH) are seen as a relative contraindication for bariatric and metabolic surgery. Several studies have shown significant improvement in liver function and liver histology after bariatric surgery. There are very few studies describing bariatric surgery in patients with PH. The purpose of this retrospective study is to evaluate the feasibility and results of laparoscopic sleeve gastrectomy (SG) in patients with PH. MATERIAL AND METHODS: We present our experience of performing laparoscopic SG in 15 patients with evidence of PH. All the patients were Childs Pugh Criteria A. PH was confirmed by the presence of dilated esophageal varices on endoscopy. RESULTS: The mean operative time was 77.33 ± 15.22 min and mean blood loss was 80.67 ± 37.12 ml. The mean length of stay was 2.73 ± 0.59 days. There were no intraoperative or immediate postoperative complications. None of the patients required blood transfusion in the postoperative period. The weight, BMI, Excess body weight loss% (EBWL%), Total weight loss (TWL) and TWL% at 1 year were 86.05 ± 14.40 kg, 31.16 kg/m2 ± 3.82, 63.84% ± 15.24, 31.49 ± 9.54 kg and 26.50 ± 5.42%, respectively. Diabetes and hypertension resolution at 1 year was 80% and 72.72%, respectively. All the patients were followed up for mean 3 ± 1.5 years. There were no immediate or long-term morbidity and mortality noted. CONCLUSION: SG is a feasible and safe option for the treatment of obesity in carefully selected patients with PH with good weight loss and comorbidity resolution.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Mittal T, Ahuja A, Dey A, et al. Safety and efficacy of laparoscopic sleeve gastrectomy in patients with portal hypertension with liver function of Childs A. Surg Endosc. 2021. PMID: 34129090. doi:10.1007/s00464-021-08587-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。